M
Marco Valgimigli
Researcher at University of Bern
Publications - 772
Citations - 91095
Marco Valgimigli is an academic researcher from University of Bern. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 105, co-authored 696 publications receiving 69184 citations. Previous affiliations of Marco Valgimigli include University of Düsseldorf & Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
Comparison of intra-procedural vs. post-stenting prolonged bivalirudin infusion for residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing: the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study.
Hector M. Garcia-Garcia,Andrea Picchi,Gennaro Sardella,Marianna Adamo,Enrico Frigoli,Ugo Limbruno,Stefano Rigattieri,Roberto Diletti,Giacomo Boccuzzi,Marco Zimarino,Marco Contarini,Filippo Russo,Paolo Calabrò,Giuseppe Andò,Ferdinando Varbella,Stefano Garducci,Cataldo Palmieri,Carlo Briguori,Kayode O. Kuku,Martina Rothenbühler,Alexios Karagiannis,Marco Valgimigli +21 more
TL;DR: A strategy of prolonged bivalirudin infusion after PPCI did not reduce residual stent strut thrombosis when compared with intra-procedural only bival IRU infusion administration and time from index to follow-up OCT imaging and the infarct vessel artery did not affect this OCT-based endpoint.
Journal ArticleDOI
Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization.
Raffaele Piccolo,Kaare H. Bønaa,Orestis Efthimiou,Olivier Varenne,Philip Urban,Christoph Kaiser,Lorenz Räber,Adam de Belder,Wouter Remkes,Arnoud W J van 't Hof,Goran Stankovic,Pedro A. Lemos,Pedro A. Lemos,Tom Wilsgaard,Jörg Reifart,Alfredo E. Rodriguez,Expedito E. Ribeiro,Patrick W. Serruys,Alex Abizaid,Manel Sabaté,Robert A. Byrne,José M. de la Torre Hernández,William Wijns,Giovanni Esposito,Peter Jüni,Stephan Windecker,Marco Valgimigli +26 more
TL;DR: In this article, drug-eluting stents (DES) reduce target-vessel revascularization compared with bare-metal stents compared with BMS, and recent data suggest that DES have the potential to decrease the...
Journal ArticleDOI
Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve Replacement
Masahiko Asami,Thomas Pilgrim,Jonas Lanz,Dik Heg,Anna Franzone,Raffaele Piccolo,Bettina Langhammer,Fabien Praz,Lorenz Räber,Marco Valgimigli,Eva Roost,Stephan Windecker,Stefan Stortecky +12 more
TL;DR: The left-ventricular myocardial performance index Tei is associated with impaired clinical outcomes during short- and longer-term follow-up after transcatheter aortic valve replacement.
Journal ArticleDOI
Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
Giulia Magnani,Marco Valgimigli +1 more
TL;DR: The optimal duration of DAPT is however an area of debate as mentioned in this paper, with the balance between the ischemic and bleeding risk carried by the patient being the most important factor.
Journal ArticleDOI
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes.
Alessandro Spirito,Angelo Quagliana,M. Coiro,Gebremedhin D. Melaku,Stijn Vandenberghe,Gregor Leibundgut,Jonas Dominik Häner,Marco Moccetti,Marco Araco,Hector Garcia Garcia,Marco Valgimigli +10 more
TL;DR: In patients with LTB, the NeVa MTD was safe and associated with high rates of vessel recanalisation and thrombus removal, and the concomitant use of vacuum-assisted aspiration has potential to improve the effectiveness and safety of the technique.